Our portfolio
Since October 2015 we have invested over €4bn in 25 platform companies across three flagship funds. We have added 26 platforms and 70+ companies to our platform, putting our teams and their companies on the global stage in specialist healthcare markets.
Avid BioServices
Avid BioServices
Current
Pure-play biologics CDMO supporting high-quality, end-to-end development and manufacturing of novel biologic therapies
Alcami Corporation
Alcami Corporation
Current
A high growth CDMO with integrated capabilities across the drug development lifecycle, including high demand labs and biostorage
Sapio Sciences
Sapio Sciences
Current
Sapio Sciences is a leading lab informatics platform providing LIMS, ELN and Data management solutions to Biopharma, CROs and clinical diagnostic labs
Genesis Research
Genesis Research
Current
Genesis is a leading provider of tech-enabled Real World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services.
Sanner
Sanner
Current
Sanner is the leading supplier of high-quality active packaging solutions supporting Pharmaceutical, Diagnostic, Nutraceutical and MedTech companies globally.
ClearView Healthcare Partners
ClearView Healthcare Partners
Current
ClearView Healthcare Partners is the leading life sciences strategic consultancy supporting Pharma and Biotech sponsors globally.
ELIQUENT Life Sciences
ELIQUENT Life Sciences
Current
ELIQUENT (formerly Validant) is a leading international provider of quality compliance and regulatory affairs consulting services to biotech, pharma and medtech companies.
Velocity Clinical Research
Velocity Clinical Research
Current
Velocity Clinical Research is a Site Management Organisation (‘SMO’) managing clinical trial sites across North America with a focus across infectious diseases, vaccine trials and general medicine therapeutic areas.
Envision Pharma Group
Envision Pharma Group
Current
Envision is the global leader in the medical affairs space, providing software and scientific solutions to the biopharma industry.
X-Chem
X-Chem
Current
X-Chem is the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services.